These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26080057)

  • 1. Association of Protein Translation and Extracellular Matrix Gene Sets with Breast Cancer Metastasis: Findings Uncovered on Analysis of Multiple Publicly Available Datasets Using Individual Patient Data Approach.
    Chowdhury N; Sapru S
    PLoS One; 2015; 10(6):e0129610. PubMed ID: 26080057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene modules associated with breast cancer distant metastasis-free survival in the PAM50 molecular subtypes.
    Liu R; Zhang W; Liu ZQ; Zhou HH
    Oncotarget; 2016 Apr; 7(16):21686-98. PubMed ID: 26934123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
    Gene; 2022 May; 821():146328. PubMed ID: 35181505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.
    Kimbung S; Johansson I; Danielsson A; Veerla S; Egyhazi Brage S; Frostvik Stolt M; Skoog L; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Loman N; Malmström PO; Söderberg M; Walz TM; Fernö M; Hatschek T; Hedenfalk I;
    Clin Cancer Res; 2016 Jan; 22(1):146-57. PubMed ID: 26276891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer.
    Winslow S; Lindquist KE; Edsjö A; Larsson C
    BMC Cancer; 2016 Nov; 16(1):841. PubMed ID: 27809802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and validation of breast cancer subtypes.
    Kapp AV; Jeffrey SS; Langerød A; Børresen-Dale AL; Han W; Noh DY; Bukholm IR; Nicolau M; Brown PO; Tibshirani R
    BMC Genomics; 2006 Sep; 7():231. PubMed ID: 16965636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer molecular profiling with single sample predictors: a retrospective analysis.
    Weigelt B; Mackay A; A'hern R; Natrajan R; Tan DS; Dowsett M; Ashworth A; Reis-Filho JS
    Lancet Oncol; 2010 Apr; 11(4):339-49. PubMed ID: 20181526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of a 92-probe signature in breast cancer.
    Akter S; Choi TG; Nguyen MN; Matondo A; Kim JH; Jo YH; Jo A; Shahid M; Jun DY; Yoo JY; Nguyen NN; Seo SW; Ali L; Lee JS; Yoon KS; Choe W; Kang I; Ha J; Kim J; Kim SS
    Oncotarget; 2015 Jun; 6(17):15662-80. PubMed ID: 25883221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.
    Fan C; Prat A; Parker JS; Liu Y; Carey LA; Troester MA; Perou CM
    BMC Med Genomics; 2011 Jan; 4():3. PubMed ID: 21214954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular portraits of breast tumors are conserved across microarray platforms.
    Hu Z; Fan C; Oh DS; Marron JS; He X; Qaqish BF; Livasy C; Carey LA; Reynolds E; Dressler L; Nobel A; Parker J; Ewend MG; Sawyer LR; Wu J; Liu Y; Nanda R; Tretiakova M; Ruiz Orrico A; Dreher D; Palazzo JP; Perreard L; Nelson E; Mone M; Hansen H; Mullins M; Quackenbush JF; Ellis MJ; Olopade OI; Bernard PS; Perou CM
    BMC Genomics; 2006 Apr; 7():96. PubMed ID: 16643655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer.
    Konstantinopoulos PA; Cannistra SA; Fountzilas H; Culhane A; Pillay K; Rueda B; Cramer D; Seiden M; Birrer M; Coukos G; Zhang L; Quackenbush J; Spentzos D
    PLoS One; 2011 Mar; 6(3):e18202. PubMed ID: 21479231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene-expression signature as a predictor of survival in breast cancer.
    van de Vijver MJ; He YD; van't Veer LJ; Dai H; Hart AA; Voskuil DW; Schreiber GJ; Peterse JL; Roberts C; Marton MJ; Parrish M; Atsma D; Witteveen A; Glas A; Delahaye L; van der Velde T; Bartelink H; Rodenhuis S; Rutgers ET; Friend SH; Bernards R
    N Engl J Med; 2002 Dec; 347(25):1999-2009. PubMed ID: 12490681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling for prognosis using Cox regression.
    Pawitan Y; Bjöhle J; Wedren S; Humphreys K; Skoog L; Huang F; Amler L; Shaw P; Hall P; Bergh J
    Stat Med; 2004 Jun; 23(11):1767-80. PubMed ID: 15160407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving gene set analysis of microarray data by SAM-GS.
    Dinu I; Potter JD; Mueller T; Liu Q; Adewale AJ; Jhangri GS; Einecke G; Famulski KS; Halloran P; Yasui Y
    BMC Bioinformatics; 2007 Jul; 8():242. PubMed ID: 17612399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.